Effects of Ciloistazol VCAM-1NF-KB and PPARs in Aorta of STZ-induced Diabetes
WANG Fu-rong,GAO Ling,YU Jian-zhon,ZHANG Jie,ZHANG Xiu-me,WAN Qiang,LIU Yi,HUANG Chuan-kui,ZHAO Jia-jun
DOI: https://doi.org/10.3321/j.issn:1001-1978.2006.02.016
2006-01-01
Abstract:Aim To investigate the in vivo effects of cilostazol,a novel phosphodiesterase III inhibitor,on signaling regulation,that is PPARs and NF-κB on vascular cell adhesion molecule-1(VCAM-1) in aorta of diabetic rats.Methods Diabetes was induced by intraperitoneally injecting fasted SD rats with streptozocin(STZ) at the dose of 65 mg· kg~(-1).32 diabetic rats were randomly divided into three groups,diabetes mellitus group(DM,n=12),high dosage of cilostazol group(GX,27 mg·kg~(-1)·d~(-1),n=10) and low dosage of cilostazol(DX,9 mg·kg~(-1)·d~(-1),n=10),plus normal control group(NC,n=8).After treatment for 8 weeks,using immunohistochemitry(IHC),in situ hybridyzation(ISH) and electrophoresis mobility shift assay(EMSA),we determined expression of VCAM-1,translocation of P65 subunit and activity of NF-κB in aorta tissues.PPARα and PPARγ were examined by RT-PCR or Real-Time PCR.Results ①Compared with NC group,diabetic groups had elevated VCAM-1 expression of protein and mRNA(P0.01),and increased activation and translocation of NF-κB(P0.01) on rat aortic artery endothelial surface.PPARr mRNA was increased 1.7 times and PPARα mRNA was decreased(P0.01) in DM group.② High dose of cilostazol suppressed VCAM-1 expression of protein and mRNA,activation and translocation of NF-κB(P0.01).Reduction of PPARγ mRNA in GX group was 73% compared with that of DM group,but PPARα was up-regulated(P0.05).Conclusion As PPARs may have some effects on NF-κB,our findings first provide potential new insight into the possible mechanism of cilostazol on NF-κB-by PPARs.This provides an experimental evidence for further evaluation of the diabetic macroangiopathy protective effect of cilostazol.